bioRxivPharmacology & ToxicologyPreprint
The effects of chronic neuropathic pain states on the discriminative stimulus effect of fentanyl and other MOR agonists
Gwendolyn E. Burgess, John R. TraynoriD, Emily M. JutkiewicziD
Abstract
Pleasant subjective effects of drugs (e.g., euphoria) have been demonstrated to contribute to their abuse potential. In humans, there is some evidence that acute pain states may decrease the positive subjective effects of opioids; however, no studies have directly tested the impact of a long-lasting pain state. Therefore, the goal of this study was to directly evaluate the discriminative stimulus of mu opioid receptor (MOR) agonist, fentanyl, or the non-opioid drug of abuse, cocaine, in the presence or absence of spared nerve injury (SNI) induced chronic neuropathic pain. Prior to surgery, MOR agonists (fentanyl, morphine, nalbuphine) dose-dependently increased % fentanyl-like responding, as expected; surprisingly, after surgery, we saw small, significant rightward shifts in the fentanyl and morphine dose response curves in both sham and SNI groups suggesting that the observed shifts were not due to chronic pain. In both sham and SNI groups, there was an increase in the generalization of nalbuphine to the fentanyl-discriminative stimulus. There was no change in the discriminative stimulus of cocaine (or amphetamine substitutions) over 4 months of SNI-induced chronic neuropathic pain or sham states, suggesting that the SNI model failed to alter the discriminative stimuli of fentanyl and cocaine. Following induction of chronic neuropathic pain, there was an observed increase in quinpirole-induced generalization to the cocaine discriminative stimulus. In the future, studies should directly examine the abuse potential of low efficacy MOR agonists and dopaminergic agonists in the presence and absence of chronic pain states. Significance StatementSubjective or interoceptive effects of drugs of abuse are known to contribute to the abuse potential. This study demonstrated that long-lasting neuropathic pain failed to alter the discriminative stimulus of mu opioid receptor agonists or cocaine; however, we observed an increase in quinpirole-induced generalization to the cocaine discriminative stimulus, suggesting the abuse potential of direct dopaminergic agonists should be further evaluated in the presence or absence of pain states.
- organism: mouse
- assay: behavioral assay
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The effects of chronic neuropathic pain on the self-administration of highly potent MOR agonist, fentanyl
Gwendolyn E. Burgess, John R. Traynor, Emily M. Jutkiewicz·bioRxiv·Nov 19, 2024
- The effects of chronic neuropathic pain states on MOR-agonist induced antihyperalgesic-like effects and rate suppressant effects
Gwendolyn E. Burgess, Hailey Y. Rizk, … Emily M. Jutkiewicz·bioRxiv·Aug 5, 2025
- Neuropathic pain has sex-specific effects on oxycodone seeking and drug-seeking ensembles in the dorsomedial prefrontal cortex
B. C. Sarka, S. Liu, … C. M. Olsen·bioRxiv·Jul 6, 2023
- Pattern of Self-Administered Vapor Fentanyl Exposure Determines Long-term Behavior Consequences, in Mice with or without Neuropathic Pain
Samantha Cermak, Maria Virginia Centeno, … A. Vania Apkarian·bioRxiv·Sep 22, 2022
- Nucleus accumbens sub-regions experience distinct dopamine release responses following acute and chronic morphine exposure
Sarah Warren Gooding, Elinor Lewis, … Jennifer Lynne Whistler·bioRxiv·Jun 28, 2024
- A peripherally restricted cannabinoid 1 receptor agonist provides analgesic benefit from neuropathic pain and a lack of addiction-related behavior
Amie L. Severino, Lindsay M. Lueptow, … Catherine M. Cahill·bioRxiv·Apr 15, 2026